Trial Profile
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2019
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms LIVE-C-Free
- 12 Jul 2018 Status changed from active, no longer recruiting to completed.
- 16 May 2018 Planned primary completion date changed from 1 Jun 2017 to 1 May 2018.
- 16 May 2018 Status changed from recruiting to active, no longer recruiting.